Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fischer

Showing results (611-620 of 671) with videos related to

Pageof 68
Sort By:
Leukemia|August 6, 2015
Specificity of JAK-kinase inhibition determines impact on human and murine T-cell functionF Perner, T M Schnöder, S Ranjan, et al.
Vaccine|September 25, 2018
Dynamic changes of circulating miRNAs induced by the Ebola virus vaccine VSV-EBOVT Fischer, M Spohn, F Olearo, et al.
Leukemia|October 22, 2015
Impact of FLT3-ITD location on sensitivity to TKI-therapy in vitro and in vivoP Arreba-Tutusaus, T S Mack, L Bullinger, et al.
Leukemia|March 20, 2013
A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signalingA Caldarelli, J P Müller, M Paskowski-Rogacz, et al.
Bone Marrow Transplantation|June 19, 1998
Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CMLT Fischer, A Neubauer, J Mohm, et al.
Leukemia|May 26, 2012
Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemiaR M Stone, T Fischer, R Paquette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trialE Heidemann, H Stoeger, R Souchon, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 30, 2020
[Cold atmospheric pressure plasma for the treatment of acute and chronic wounds]S Emmert, A van Welzen, K Masur, et al.
Annals of Hematology|February 9, 2000
Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML)A Ganser, G Heil, G Seipelt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 15, 2015
Elevated ST2 Distinguishes Incidences of Pediatric Heart and Small Bowel Transplant RejectionL R Mathews, J M Lott, K Isse, et al.
Pageof 68

Showing results (611-620 of 671) with videos related to

Sort By:
Pageof 68
Leukemia|August 6, 2015
Specificity of JAK-kinase inhibition determines impact on human and murine T-cell functionF Perner, T M Schnöder, S Ranjan, et al.
Vaccine|September 25, 2018
Dynamic changes of circulating miRNAs induced by the Ebola virus vaccine VSV-EBOVT Fischer, M Spohn, F Olearo, et al.
Leukemia|October 22, 2015
Impact of FLT3-ITD location on sensitivity to TKI-therapy in vitro and in vivoP Arreba-Tutusaus, T S Mack, L Bullinger, et al.
Leukemia|March 20, 2013
A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signalingA Caldarelli, J P Müller, M Paskowski-Rogacz, et al.
Bone Marrow Transplantation|June 19, 1998
Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CMLT Fischer, A Neubauer, J Mohm, et al.
Leukemia|May 26, 2012
Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemiaR M Stone, T Fischer, R Paquette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trialE Heidemann, H Stoeger, R Souchon, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 30, 2020
[Cold atmospheric pressure plasma for the treatment of acute and chronic wounds]S Emmert, A van Welzen, K Masur, et al.
Annals of Hematology|February 9, 2000
Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML)A Ganser, G Heil, G Seipelt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 15, 2015
Elevated ST2 Distinguishes Incidences of Pediatric Heart and Small Bowel Transplant RejectionL R Mathews, J M Lott, K Isse, et al.
Pageof 68